Stem Cell Therapeutics Corp. Announces Completion of Further Analysis of the Modified REGENESIS Stroke Data
CALGARY, ALBERTA–(Marketwire – 09/09/10) – Stem Cell Therapeutics Corp. (”SCT” or the “Company”) (TSX-V: SSS – News ) wishes to announce that further analyses of the modified REGENESIS stroke data base have been completed. First, no dose-related treatment mortality was seen, confirming our earlier observations. Second, in those patients who received occupational therapy (OT) – approximately 25 …
[Read the full article here]Related News:
Stem Cell Therapeutics Corp. Announces Completion of Further Analysis of the …
Stem Cell Therapeutics Corp. Announces Completion of Enrollment in Key Modified REGENESIS Phase IIb Stroke Trial
Stem Cell Therapeutics Corp. Announces The Date For The Release Of Top-Line Results In The Modified REGENESIS Phase …